Drug Development

Widely touted in multiple sclerosis patient communities, low-dose naltrexone does appear to improve disease scores in about half of mice with an experimentally induced version of MS. Researchers found a similar pattern of results with met-enkephalin.

In a head-to-head comparison of four MS models, one based on HSV-1 infection shows its value

Medical Cannabis for MS; Rare Complication From Interferon-β; Genzyme to Try Again With Alemtuzumab; Retracted MS Paper